$SINT
Sintx Technologies, Inc. Stock $sint

$sint Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224018961 Filed on May 13, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$859.0K	$687.0K	$539.0K
YoY Change	69.09%	27.46%	317.83%
Cost Of Revenue	$224.0K	$223.0K	$118.0K
YoY Change	115.38%	88.98%	47.5%
Gross Profit	$635.0K	$464.0K	$421.0K
YoY Change	57.18%	10.21%	759.18%
Gross Profit Margin	73.92%	67.54%	78.11%
Selling, General & Admin	$1.328M	$1.369M	$1.479M
YoY Change	-10.03%	-7.44%	18.32%
% of Gross Profit	209.13%	295.04%	351.31%
Research & Development	$1.677M	$2.019M	$2.200M
YoY Change	-21.93%	-8.23%	33.09%
% of Gross Profit	264.09%	435.13%	522.57%
Depreciation & Amortization	$262.0K	$256.0K	$154.0K
YoY Change	18.02%	66.23%	123.19%
% of Gross Profit	41.26%	55.17%	36.58%
Operating Expenses	$3.345M	$3.661M	$3.978M
YoY Change	-13.52%	-7.97%	35.81%
Operating Profit	-$2.710M	-$3.197M	-$3.557M
YoY Change	-21.77%	-10.12%	23.51%
Interest Expense	$467.0K	$2.855M	$4.042M
YoY Change	-53.85%	-29.37%	11448.57%
% of Operating Profit
Other Income/Expense, Net	$506.0K	$2.311M	$3.264M
YoY Change	-49.85%	-29.2%
Pretax Income	-$2.204M	-$886.0K	-$293.0K
YoY Change	-10.22%	202.39%	-89.7%
Income Tax
% Of Pretax Income
Net Earnings	-$2.204M	-$886.0K	-$293.0K
YoY Change	-10.22%	202.39%	-89.7%
Net Earnings / Revenue	-256.58%	-128.97%	-54.36%
Basic Earnings Per Share	-$3.49	-$0.05	-$0.13
Diluted Earnings Per Share	-$3.61	-$0.11	-$0.13
COMMON SHARES
Basic Shares Outstanding	122.7M shares	22.68M shares	3.924M shares
Diluted Shares Outstanding	697.9K shares	34.46M shares	2.558M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.557M	$5.762M	$12.63M
YoY Change	-51.15%	-54.36%	16.23%
Cash & Equivalents	$4.557M	$5.762M	$12.63M
Short-Term Investments
Other Short-Term Assets	$41.00K	$196.0K	$25.00K
YoY Change	173.33%	684.0%	-96.53%
Inventory	$1.020M	$1.176M	$626.0K
Prepaid Expenses
Receivables	$434.0K	$483.0K	$467.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.861M	$7.514M	$14.29M
YoY Change	-47.2%	-47.42%	19.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.815M	$5.064M	$5.772M
YoY Change	-14.79%	-12.27%	-10.37%
Goodwill
YoY Change
Intangibles	$19.00K	$20.00K	$25.00K
YoY Change	-20.83%	-20.0%
Long-Term Investments
YoY Change
Other Assets	$235.0K	$558.0K	$84.00K
YoY Change	193.75%	564.29%	-80.19%
Total Long-Term Assets	$9.435M	$10.05M	$8.360M
YoY Change	17.97%	20.18%	21.26%
TOTAL ASSETS
Total Short-Term Assets	$5.861M	$7.514M	$14.29M
Total Long-Term Assets	$9.435M	$10.05M	$8.360M
Total Assets	$15.30M	$17.56M	$22.65M
YoY Change	-19.91%	-22.47%	19.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$331.0K	$448.0K	$486.0K
YoY Change	-34.06%	-7.82%	-0.82%
Accrued Expenses	$1.558M	$2.041M	$1.504M
YoY Change	3.38%	35.7%	11.74%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$241.0K	$233.0K	$117.0K
YoY Change	156.38%	99.15%
Total Short-Term Liabilities	$3.021M	$4.088M	$5.126M
YoY Change	-23.05%	-20.25%	92.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$33.00K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$3.429M	$3.547M
YoY Change
Total Long-Term Liabilities	$3.429M	$3.547M	$33.00K
YoY Change	26276.92%	10648.48%	-98.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.021M	$4.088M	$5.126M
Total Long-Term Liabilities	$3.429M	$3.547M	$33.00K
Total Liabilities	$6.450M	$7.635M	$6.706M
YoY Change	22.02%	13.85%	51.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$273.8M	-$271.6M	-$262.7M
YoY Change	3.24%	3.39%
Common Stock	$7.000K	$511.0K	$40.00K
YoY Change	-83.33%	1177.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.846M	$9.926M	$15.95M
YoY Change
Total Liabilities & Shareholders Equity	$15.30M	$17.56M	$22.65M
YoY Change	-19.91%	-22.47%	19.95%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$2.204M	-$886.0K	-$293.0K
YoY Change	-10.22%	202.39%	-89.7%
Depreciation, Depletion And Amortization	$262.0K	$256.0K	$154.0K
YoY Change	18.02%	66.23%	123.19%
Cash From Operating Activities	-$2.215M	-$2.700M	-$4.900M
YoY Change	-30.78%	-44.9%	54.09%
INVESTING ACTIVITIES
Capital Expenditures	$359.0K	$174.0K	$236.0K
YoY Change	266.33%	-26.27%	-202.61%
Acquisitions
YoY Change
Other Investing Activities	$359.0K	$1.000K
YoY Change
Cash From Investing Activities	$0.00	-$173.0K	-$236.0K
YoY Change	-100.0%	-26.69%	2.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.010M	$5.328M	$11.49M
YoY Change		-53.62%
NET CHANGE
Cash From Operating Activities	-2.215M	-$2.700M	-$4.900M
Cash From Investing Activities	0.000	-$173.0K	-$236.0K
Cash From Financing Activities	1.010M	$5.328M	$11.49M
Net Change In Cash	-1.205M	$2.422M	$6.381M
YoY Change	-63.46%	-62.04%
FREE CASH FLOW
Cash From Operating Activities	-$2.215M	-$2.700M	-$4.900M
Capital Expenditures	$359.0K	$174.0K	$236.0K
Free Cash Flow	-$2.574M	-$2.874M	-$5.136M
YoY Change	-21.95%	-44.04%	74.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001269026
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	SINT	Stock Issued During Period Value Of Common Stock From Exercise Of Prefunded Warrants For Cash StockIssuedDuringPeriodValueOfCommonStockFromExerciseOfPrefundedWarrantsForCash		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q1	SINT	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023Q1	SINT	Proceeds From Issuance Of Common Stock Exercise Of Warrants ProceedsFromIssuanceOfCommonStockExerciseOfWarrants		usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2024Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock		usd
CY2023Q1	SINT	Increase In Property Plant And Equipment From Accrual IncreaseInPropertyPlantAndEquipmentFromAccrual		usd
CY2023Q1	SINT	Debt Issued For Prepaid Insurance DebtIssuedForPrepaidInsurance		usd
CY2023Q1	SINT	Agent Warrant Offering Cost Allocated To Equity AgentWarrantOfferingCostAllocatedToEquity		usd
CY2023Q1	SINT	Right Of Use Asset For Amended Lease Liability Increase RightOfUseAssetForAmendedLeaseLiabilityIncrease		usd
CY2024Q1	SINT	Right Of Use Asset For Lease Liability RightOfUseAssetForLeaseLiability		usd
CY2024Q1	SINT	Reduction Of Derivative Liability Upon Exercise Of Warrants ReductionOfDerivativeLiabilityUponExerciseOfWarrants		usd
CY2024Q1	SINT	Par Value Of Common Stock Upon Cashless Exercise Of Warrants ParValueOfCommonStockUponCashlessExerciseOfWarrants		usd
CY2024Q1	SINT	Par Value Of Common Stock Upon Exercise Of Prefunded Warrants ParValueOfCommonStockUponExerciseOfPrefundedWarrants		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	687000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	539000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	223000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	118000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	464000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	421000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2019000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2200000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1123000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1169000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	246000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	310000	usd
CY2024Q1	SINT	Grant And Contract Expenses GrantAndContractExpenses	273000	usd
CY2023Q1	SINT	Grant And Contract Expenses GrantAndContractExpenses	299000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3661000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3978000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3197000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3557000	usd
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	2000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	2000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	19000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	38000	usd
CY2024Q1	SINT	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	2838000	usd
CY2023Q1	SINT	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	4006000	usd
CY2024Q1	SINT	Offering Costs Associated With Derivative Warrant Liabilities OfferingCostsAssociatedWithDerivativeWarrantLiabilities	550000	usd
CY2023Q1	SINT	Offering Costs Associated With Derivative Warrant Liabilities OfferingCostsAssociatedWithDerivativeWarrantLiabilities	786000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2311000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3264000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-886000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-293000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-886000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.74
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17262895	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2272992	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34460877	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2558059	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5704000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	86000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4457000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	383000	usd
CY2023Q1	SINT	Adjustments To Additional Paid In Capital Extinguishment Of Derivative Liability Upon Exercise Of Warrant AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivativeLiabilityUponExerciseOfWarrant	5502000	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-2000	usd
CY2023Q1	SINT	Adjustments To Additional Paid In Capital Issuance Of Agent Warrants AdjustmentsToAdditionalPaidInCapitalIssuanceOfAgentWarrants	108000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	15945000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8772000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-886000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	9926000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	9926000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	256000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	154000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	163000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	183000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	50000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	86000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2838000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3898000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	37000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-165000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	137000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-286000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	457000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-45000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-110000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	128000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-103000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-337000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-140000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-177000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2733000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4871000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	174000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	236000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-173000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-236000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3366000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	6650000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2003000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4840000	usd
CY2024Q1	SINT	Proceeds From Issuance Of Common Stock Exercise Of Warrants ProceedsFromIssuanceOfCommonStockExerciseOfWarrants	1000	usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	42000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5328000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11488000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2422000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6381000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3340000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6245000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5762000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12626000	usd
CY2024Q1	SINT	Increase In Property Plant And Equipment From Accrual IncreaseInPropertyPlantAndEquipmentFromAccrual	319000	usd
CY2024Q1	SINT	Debt Issued For Prepaid Insurance DebtIssuedForPrepaidInsurance	229000	usd
CY2024Q1	SINT	Agent Warrant Offering Cost Allocated To Equity AgentWarrantOfferingCostAllocatedToEquity	13000	usd
CY2024Q1	SINT	Right Of Use Asset For Amended Lease Liability Increase RightOfUseAssetForAmendedLeaseLiabilityIncrease	4000	usd
CY2023Q1	SINT	Right Of Use Asset For Lease Liability RightOfUseAssetForLeaseLiability	114000	usd
CY2023Q1	SINT	Reduction Of Derivative Liability Upon Exercise Of Warrants ReductionOfDerivativeLiabilityUponExerciseOfWarrants	5502000	usd
CY2023Q1	SINT	Par Value Of Common Stock Upon Cashless Exercise Of Warrants ParValueOfCommonStockUponCashlessExerciseOfWarrants	13000	usd
CY2023Q1	SINT	Par Value Of Common Stock Upon Exercise Of Prefunded Warrants ParValueOfCommonStockUponExerciseOfPrefundedWarrants	2000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	2000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zJmwXVn0hax5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zb6i6wpedyib">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. As of March 31, 2024, the most significant estimate relates to derivative liabilities relating to common stock warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-900000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2700000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4900000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-271600000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-270700000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2150000	shares
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	16000000	shares
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.25
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	28400000	shares
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.047
CY2024Q1	SINT	Offering Expenses Payable OfferingExpensesPayable	1300000	usd
CY2023Q4	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies State And Local EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal	0.05	pure
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18100000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1200000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-886000	usd
CY2024Q1	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-2846000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3732000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17262895	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	17197982	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34460877	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q1	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare	-0.17
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-293000	usd
CY2023Q1	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-4149000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-4442000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2272992	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	258067	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2558059	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q1	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare	-1.61
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.74
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	732000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	691000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	335000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	426000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	109000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	104000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1176000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1221000	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	700000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	500000	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	845000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	304000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	851000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	610000	usd
CY2024Q1	SINT	Accrued Payable Current AccruedPayableCurrent	568000	usd
CY2023Q4	SINT	Accrued Payable Current AccruedPayableCurrent	163000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	622000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	631000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2041000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1404000	usd
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	16000000	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3400000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	SINT	Offering Expenses Payable OfferingExpensesPayable	4000000	usd
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.25
CY2024Q1	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.070	pure
CY2024Q1	SINT	Reimbursement Of Expenses And Legal Fees ReimbursementOfExpensesAndLegalFees	100000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	640000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.275
CY2024Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2024Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	28400000	shares
CY2024Q1	us-gaap	Share Price SharePrice	0.047
CY2024Q1	SINT	Offering Expenses Payable OfferingExpensesPayable	1300000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2150000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.60
CY2024Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1030519000000	usd
CY2024Q1	SINT	Public Float Threshold PublicFloatThreshold	75000000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	109.77
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	82.75
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M12D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10838	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	140.68
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y9M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9571	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	82.43
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	234.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	120.33
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8303	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	330.56
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9840	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	119.65
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y8M12D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11909	shares
CY2024Q1	us-gaap	Area Of Land AreaOfLand	30764	sqft
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3900000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4100000	usd
CY2024Q1	SINT	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	200000	usd
CY2023Q1	SINT	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	200000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.087	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	643000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	738000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	668000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	688000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	709000	usd
CY2024Q1	SINT	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	2124000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5570000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1505000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4065000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	518000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3547000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2024Q2	us-gaap	Share Price SharePrice	0.10
CY2024Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	71600000	shares
CY2024Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.021
CY2024Q2	SINT	Offering Expenses Payable OfferingExpensesPayable	1500000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-018961-index-headers.html	Edgar Link	pending
0001493152-24-018961-index.html	Edgar Link	pending
0001493152-24-018961.txt	Edgar Link	pending
0001493152-24-018961-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sint-20240331.xsd	Edgar Link	pending
sint-20240331_def.xml	Edgar Link	unprocessable
sint-20240331_lab.xml	Edgar Link	unprocessable
sint-20240331_pre.xml	Edgar Link	unprocessable
sint-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SINT
Sintx Technologies, Inc. Stock $sint

2024 Q2 Form 10-Q Financial Statement

#000149315224018961 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT Sintx Technologies, Inc. Stock $sint

2024 Q2 Form 10-Q Financial Statement

#000149315224018961 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT
Sintx Technologies, Inc. Stock $sint